Welcome to CLIRINX! We're dedicated to advancing epilepsy and rare disease research through improved IT tools. Whether you're a researcher, advocate, or seeking resources, we're here to enhance your data collection process.
CLIRINX provides IT expertise for patient registries, natural history studies, clinical trial readiness, and research. Our expert team guides researchers through the IT components from study design to close-out, committed to advancing epilepsy and rare disease research.
We offer 21CFR11-compliant web tools to support research, speeding up discovery for new cures and treatments. Our range includes study management, data collection, and participant portals, among other advanced IT solutions. Dedicated to internet-based research, team science, and disease advocacy.
Electronic Data Collection
Patient Portal / Data sharing
Adjudication workflows
Translation Engine
Clinical Research ID
Data into visual insights
Unlock your data
Genetic Variant Tracker
Terabytes to petabytes...
Health informatics databases
Security measures include SSL (encryption), encryption of data at rest, unique user names and passwords, single sign-on (Okta), role based access, digital signatures, full audit log and data change history, version controlled CRFs and study documents, restricted/encrypted PHI fields, two-factor authentication, multi-Blockchain document timestamps, IP/geolocation restrictions, OS level security, servers only accessible behind firewall or SSH with private key encryption. We also have Cyber and PI Insurance to protect our business and our customers. All these security and privacy features will help to support your HIPAA and 21CFR11 compliance efforts.
You own the data you collect. And, unlike some other software providers, CLIRINX will never analyze, share or sell the data you collect using the CLIRINX software.
Oct 3, 2024 CRID 'Clinical Research ID' nears 6000 CRID identifiers!
Sep 2, 2024 New Clinical System launched @ Univ. of Melbourne
Jul 1, 2024 The RDDR is now live. https://theRDDR.org
Apr 24, 2024 CLIRINX & CRID feature in new major SCN2A-related publication.